Changes in brain natriuretic peptide in chronic heart failure patients treated with long-acting versus short-acting loop diuretics: J-MELODIC subanalysis
We have previously reported that a long-acting loop diuretic, azosemide, reduces cardiovascular risks in patients with chronic heart failure (CHF) as compared with a short-acting one, furosemide, in Japanese Multicenter Evaluation of LOng- versus short-acting Diuretics In Congestive heart failure (J...
Gespeichert in:
| Veröffentlicht in: | Heart and vessels 2017-07, Vol.32 (7), p.865-871 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 871 |
|---|---|
| container_issue | 7 |
| container_start_page | 865 |
| container_title | Heart and vessels |
| container_volume | 32 |
| creator | Fukui, Miho Tsujino, Takeshi Hirotani, Shinichi Ito, Hiroshi Yamamoto, Kazuhiro Akasaka, Takashi Hirano, Yutaka Ohte, Nobuyuki Daimon, Takashi Nakatani, Satoshi Kawabata, Masaaki Masuyama, Tohru |
| description | We have previously reported that a long-acting loop diuretic, azosemide, reduces cardiovascular risks in patients with chronic heart failure (CHF) as compared with a short-acting one, furosemide, in Japanese Multicenter Evaluation of LOng- versus short-acting Diuretics In Congestive heart failure (J-MELODIC). However, the mechanisms of the difference have not been elucidated. This study aimed to examine whether there is a difference in the reduction in plasma brain natriuretic peptide (BNP) level and in left ventricular (LV) functional recovery between the CHF patients treated with the long-acting diuretic (the azosemide group) and the short-acting diuretic (the furosemide group). We reviewed changes in plasma BNP level and echo-assessed LV functional parameters from baseline to a year after the entry in 288 CHF patients with New York Heart Association class II or III symptoms that joined J-MELODIC. The decrease in plasma BNP levels was larger in the azosemide group than in the furosemide group (
p
|
| doi_str_mv | 10.1007/s00380-017-0945-z |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1861588020</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1914768638</sourcerecordid><originalsourceid>FETCH-LOGICAL-c396t-dd649b15fcaf93ced1cee3535ec48737495dff5b6edfb9a464286a59435004593</originalsourceid><addsrcrecordid>eNp1kcFu1DAQhi1ERZfCA3BBlrj0YmrHcWJzQ9sWihb1AmfLcSYbV9kkeBxQ-ya8bb3aLUJIXGxp5pt_LH-EvBH8veC8vkDOpeaMi5pxUyr28IysRCUUK1Qtn5MVN4IzLYv6lLxEvONcKCPMC3JaaMGVEmpFfq97N24BaRhpE10-R5diWCKk4OkMcwot7Ju-j9OYSz24mGjnwpAZOrsUYExIUwSXoKW_QurpMI1b5nwK45b-hIgLUuynmJ5qwzTNtD0uwQ_0C_t6tbm9vFlTXBo3uuEeA74iJ50bEF4f7zPy_frq2_oz29x-ull_3DAvTZVY21alaYTqvOuM9NAKDyCVVOBLXcu6NKrtOtVU0HaNcWVVFrpyypRScV4qI8_I-SF3jtOPBTDZXUAPw-BGmBa0Qucf1ZoXPKPv_kHvpiXm92bKiLKudCV1psSB8nFCjNDZOYadi_dWcLv3Zg_ebPZm997sQ555e0xemh20fyaeRGWgOACYW1lY_Gv1f1MfAZFxpeM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1914768638</pqid></control><display><type>article</type><title>Changes in brain natriuretic peptide in chronic heart failure patients treated with long-acting versus short-acting loop diuretics: J-MELODIC subanalysis</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Fukui, Miho ; Tsujino, Takeshi ; Hirotani, Shinichi ; Ito, Hiroshi ; Yamamoto, Kazuhiro ; Akasaka, Takashi ; Hirano, Yutaka ; Ohte, Nobuyuki ; Daimon, Takashi ; Nakatani, Satoshi ; Kawabata, Masaaki ; Masuyama, Tohru</creator><creatorcontrib>Fukui, Miho ; Tsujino, Takeshi ; Hirotani, Shinichi ; Ito, Hiroshi ; Yamamoto, Kazuhiro ; Akasaka, Takashi ; Hirano, Yutaka ; Ohte, Nobuyuki ; Daimon, Takashi ; Nakatani, Satoshi ; Kawabata, Masaaki ; Masuyama, Tohru</creatorcontrib><description>We have previously reported that a long-acting loop diuretic, azosemide, reduces cardiovascular risks in patients with chronic heart failure (CHF) as compared with a short-acting one, furosemide, in Japanese Multicenter Evaluation of LOng- versus short-acting Diuretics In Congestive heart failure (J-MELODIC). However, the mechanisms of the difference have not been elucidated. This study aimed to examine whether there is a difference in the reduction in plasma brain natriuretic peptide (BNP) level and in left ventricular (LV) functional recovery between the CHF patients treated with the long-acting diuretic (the azosemide group) and the short-acting diuretic (the furosemide group). We reviewed changes in plasma BNP level and echo-assessed LV functional parameters from baseline to a year after the entry in 288 CHF patients with New York Heart Association class II or III symptoms that joined J-MELODIC. The decrease in plasma BNP levels was larger in the azosemide group than in the furosemide group (
p
< 0.01). The changes in echocardiographic parameters were not more favorable in the azosemide group than in the furosemide group. In conclusion, the decrease in plasma BNP levels was larger in the azosemide group than in the furosemide group. These findings may account for the better prognosis in CHF patients treated with azosemide than those with furosemide in J-MELODIC.</description><identifier>ISSN: 0910-8327</identifier><identifier>EISSN: 1615-2573</identifier><identifier>DOI: 10.1007/s00380-017-0945-z</identifier><identifier>PMID: 28105515</identifier><language>eng</language><publisher>Tokyo: Springer Japan</publisher><subject>Aged ; Aged, 80 and over ; Beta blockers ; Biomarkers - blood ; Biomedical Engineering and Bioengineering ; Brain ; Brain natriuretic peptide ; Cardiac Surgery ; Cardiology ; Chronic Disease ; Congestive heart failure ; Diuretics ; Echocardiography ; Female ; Furosemide ; Furosemide - therapeutic use ; Heart ; Heart failure ; Heart Failure - blood ; Heart Failure - drug therapy ; Humans ; Japan ; Male ; Medicine ; Medicine & Public Health ; Middle Aged ; Natriuretic Peptide, Brain - blood ; Original Article ; Patients ; Plasma ; Prospective Studies ; Recovery of function ; Sodium Potassium Chloride Symporter Inhibitors - adverse effects ; Sodium Potassium Chloride Symporter Inhibitors - therapeutic use ; Sulfanilamides - therapeutic use ; Vascular Surgery ; Ventricle</subject><ispartof>Heart and vessels, 2017-07, Vol.32 (7), p.865-871</ispartof><rights>Springer Japan 2017</rights><rights>Heart and Vessels is a copyright of Springer, 2017.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c396t-dd649b15fcaf93ced1cee3535ec48737495dff5b6edfb9a464286a59435004593</citedby><cites>FETCH-LOGICAL-c396t-dd649b15fcaf93ced1cee3535ec48737495dff5b6edfb9a464286a59435004593</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00380-017-0945-z$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00380-017-0945-z$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28105515$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fukui, Miho</creatorcontrib><creatorcontrib>Tsujino, Takeshi</creatorcontrib><creatorcontrib>Hirotani, Shinichi</creatorcontrib><creatorcontrib>Ito, Hiroshi</creatorcontrib><creatorcontrib>Yamamoto, Kazuhiro</creatorcontrib><creatorcontrib>Akasaka, Takashi</creatorcontrib><creatorcontrib>Hirano, Yutaka</creatorcontrib><creatorcontrib>Ohte, Nobuyuki</creatorcontrib><creatorcontrib>Daimon, Takashi</creatorcontrib><creatorcontrib>Nakatani, Satoshi</creatorcontrib><creatorcontrib>Kawabata, Masaaki</creatorcontrib><creatorcontrib>Masuyama, Tohru</creatorcontrib><title>Changes in brain natriuretic peptide in chronic heart failure patients treated with long-acting versus short-acting loop diuretics: J-MELODIC subanalysis</title><title>Heart and vessels</title><addtitle>Heart Vessels</addtitle><addtitle>Heart Vessels</addtitle><description>We have previously reported that a long-acting loop diuretic, azosemide, reduces cardiovascular risks in patients with chronic heart failure (CHF) as compared with a short-acting one, furosemide, in Japanese Multicenter Evaluation of LOng- versus short-acting Diuretics In Congestive heart failure (J-MELODIC). However, the mechanisms of the difference have not been elucidated. This study aimed to examine whether there is a difference in the reduction in plasma brain natriuretic peptide (BNP) level and in left ventricular (LV) functional recovery between the CHF patients treated with the long-acting diuretic (the azosemide group) and the short-acting diuretic (the furosemide group). We reviewed changes in plasma BNP level and echo-assessed LV functional parameters from baseline to a year after the entry in 288 CHF patients with New York Heart Association class II or III symptoms that joined J-MELODIC. The decrease in plasma BNP levels was larger in the azosemide group than in the furosemide group (
p
< 0.01). The changes in echocardiographic parameters were not more favorable in the azosemide group than in the furosemide group. In conclusion, the decrease in plasma BNP levels was larger in the azosemide group than in the furosemide group. These findings may account for the better prognosis in CHF patients treated with azosemide than those with furosemide in J-MELODIC.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Beta blockers</subject><subject>Biomarkers - blood</subject><subject>Biomedical Engineering and Bioengineering</subject><subject>Brain</subject><subject>Brain natriuretic peptide</subject><subject>Cardiac Surgery</subject><subject>Cardiology</subject><subject>Chronic Disease</subject><subject>Congestive heart failure</subject><subject>Diuretics</subject><subject>Echocardiography</subject><subject>Female</subject><subject>Furosemide</subject><subject>Furosemide - therapeutic use</subject><subject>Heart</subject><subject>Heart failure</subject><subject>Heart Failure - blood</subject><subject>Heart Failure - drug therapy</subject><subject>Humans</subject><subject>Japan</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Natriuretic Peptide, Brain - blood</subject><subject>Original Article</subject><subject>Patients</subject><subject>Plasma</subject><subject>Prospective Studies</subject><subject>Recovery of function</subject><subject>Sodium Potassium Chloride Symporter Inhibitors - adverse effects</subject><subject>Sodium Potassium Chloride Symporter Inhibitors - therapeutic use</subject><subject>Sulfanilamides - therapeutic use</subject><subject>Vascular Surgery</subject><subject>Ventricle</subject><issn>0910-8327</issn><issn>1615-2573</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp1kcFu1DAQhi1ERZfCA3BBlrj0YmrHcWJzQ9sWihb1AmfLcSYbV9kkeBxQ-ya8bb3aLUJIXGxp5pt_LH-EvBH8veC8vkDOpeaMi5pxUyr28IysRCUUK1Qtn5MVN4IzLYv6lLxEvONcKCPMC3JaaMGVEmpFfq97N24BaRhpE10-R5diWCKk4OkMcwot7Ju-j9OYSz24mGjnwpAZOrsUYExIUwSXoKW_QurpMI1b5nwK45b-hIgLUuynmJ5qwzTNtD0uwQ_0C_t6tbm9vFlTXBo3uuEeA74iJ50bEF4f7zPy_frq2_oz29x-ull_3DAvTZVY21alaYTqvOuM9NAKDyCVVOBLXcu6NKrtOtVU0HaNcWVVFrpyypRScV4qI8_I-SF3jtOPBTDZXUAPw-BGmBa0Qucf1ZoXPKPv_kHvpiXm92bKiLKudCV1psSB8nFCjNDZOYadi_dWcLv3Zg_ebPZm997sQ555e0xemh20fyaeRGWgOACYW1lY_Gv1f1MfAZFxpeM</recordid><startdate>20170701</startdate><enddate>20170701</enddate><creator>Fukui, Miho</creator><creator>Tsujino, Takeshi</creator><creator>Hirotani, Shinichi</creator><creator>Ito, Hiroshi</creator><creator>Yamamoto, Kazuhiro</creator><creator>Akasaka, Takashi</creator><creator>Hirano, Yutaka</creator><creator>Ohte, Nobuyuki</creator><creator>Daimon, Takashi</creator><creator>Nakatani, Satoshi</creator><creator>Kawabata, Masaaki</creator><creator>Masuyama, Tohru</creator><general>Springer Japan</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20170701</creationdate><title>Changes in brain natriuretic peptide in chronic heart failure patients treated with long-acting versus short-acting loop diuretics: J-MELODIC subanalysis</title><author>Fukui, Miho ; Tsujino, Takeshi ; Hirotani, Shinichi ; Ito, Hiroshi ; Yamamoto, Kazuhiro ; Akasaka, Takashi ; Hirano, Yutaka ; Ohte, Nobuyuki ; Daimon, Takashi ; Nakatani, Satoshi ; Kawabata, Masaaki ; Masuyama, Tohru</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c396t-dd649b15fcaf93ced1cee3535ec48737495dff5b6edfb9a464286a59435004593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Beta blockers</topic><topic>Biomarkers - blood</topic><topic>Biomedical Engineering and Bioengineering</topic><topic>Brain</topic><topic>Brain natriuretic peptide</topic><topic>Cardiac Surgery</topic><topic>Cardiology</topic><topic>Chronic Disease</topic><topic>Congestive heart failure</topic><topic>Diuretics</topic><topic>Echocardiography</topic><topic>Female</topic><topic>Furosemide</topic><topic>Furosemide - therapeutic use</topic><topic>Heart</topic><topic>Heart failure</topic><topic>Heart Failure - blood</topic><topic>Heart Failure - drug therapy</topic><topic>Humans</topic><topic>Japan</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Natriuretic Peptide, Brain - blood</topic><topic>Original Article</topic><topic>Patients</topic><topic>Plasma</topic><topic>Prospective Studies</topic><topic>Recovery of function</topic><topic>Sodium Potassium Chloride Symporter Inhibitors - adverse effects</topic><topic>Sodium Potassium Chloride Symporter Inhibitors - therapeutic use</topic><topic>Sulfanilamides - therapeutic use</topic><topic>Vascular Surgery</topic><topic>Ventricle</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fukui, Miho</creatorcontrib><creatorcontrib>Tsujino, Takeshi</creatorcontrib><creatorcontrib>Hirotani, Shinichi</creatorcontrib><creatorcontrib>Ito, Hiroshi</creatorcontrib><creatorcontrib>Yamamoto, Kazuhiro</creatorcontrib><creatorcontrib>Akasaka, Takashi</creatorcontrib><creatorcontrib>Hirano, Yutaka</creatorcontrib><creatorcontrib>Ohte, Nobuyuki</creatorcontrib><creatorcontrib>Daimon, Takashi</creatorcontrib><creatorcontrib>Nakatani, Satoshi</creatorcontrib><creatorcontrib>Kawabata, Masaaki</creatorcontrib><creatorcontrib>Masuyama, Tohru</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Heart and vessels</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fukui, Miho</au><au>Tsujino, Takeshi</au><au>Hirotani, Shinichi</au><au>Ito, Hiroshi</au><au>Yamamoto, Kazuhiro</au><au>Akasaka, Takashi</au><au>Hirano, Yutaka</au><au>Ohte, Nobuyuki</au><au>Daimon, Takashi</au><au>Nakatani, Satoshi</au><au>Kawabata, Masaaki</au><au>Masuyama, Tohru</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Changes in brain natriuretic peptide in chronic heart failure patients treated with long-acting versus short-acting loop diuretics: J-MELODIC subanalysis</atitle><jtitle>Heart and vessels</jtitle><stitle>Heart Vessels</stitle><addtitle>Heart Vessels</addtitle><date>2017-07-01</date><risdate>2017</risdate><volume>32</volume><issue>7</issue><spage>865</spage><epage>871</epage><pages>865-871</pages><issn>0910-8327</issn><eissn>1615-2573</eissn><abstract>We have previously reported that a long-acting loop diuretic, azosemide, reduces cardiovascular risks in patients with chronic heart failure (CHF) as compared with a short-acting one, furosemide, in Japanese Multicenter Evaluation of LOng- versus short-acting Diuretics In Congestive heart failure (J-MELODIC). However, the mechanisms of the difference have not been elucidated. This study aimed to examine whether there is a difference in the reduction in plasma brain natriuretic peptide (BNP) level and in left ventricular (LV) functional recovery between the CHF patients treated with the long-acting diuretic (the azosemide group) and the short-acting diuretic (the furosemide group). We reviewed changes in plasma BNP level and echo-assessed LV functional parameters from baseline to a year after the entry in 288 CHF patients with New York Heart Association class II or III symptoms that joined J-MELODIC. The decrease in plasma BNP levels was larger in the azosemide group than in the furosemide group (
p
< 0.01). The changes in echocardiographic parameters were not more favorable in the azosemide group than in the furosemide group. In conclusion, the decrease in plasma BNP levels was larger in the azosemide group than in the furosemide group. These findings may account for the better prognosis in CHF patients treated with azosemide than those with furosemide in J-MELODIC.</abstract><cop>Tokyo</cop><pub>Springer Japan</pub><pmid>28105515</pmid><doi>10.1007/s00380-017-0945-z</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0910-8327 |
| ispartof | Heart and vessels, 2017-07, Vol.32 (7), p.865-871 |
| issn | 0910-8327 1615-2573 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1861588020 |
| source | MEDLINE; SpringerLink Journals |
| subjects | Aged Aged, 80 and over Beta blockers Biomarkers - blood Biomedical Engineering and Bioengineering Brain Brain natriuretic peptide Cardiac Surgery Cardiology Chronic Disease Congestive heart failure Diuretics Echocardiography Female Furosemide Furosemide - therapeutic use Heart Heart failure Heart Failure - blood Heart Failure - drug therapy Humans Japan Male Medicine Medicine & Public Health Middle Aged Natriuretic Peptide, Brain - blood Original Article Patients Plasma Prospective Studies Recovery of function Sodium Potassium Chloride Symporter Inhibitors - adverse effects Sodium Potassium Chloride Symporter Inhibitors - therapeutic use Sulfanilamides - therapeutic use Vascular Surgery Ventricle |
| title | Changes in brain natriuretic peptide in chronic heart failure patients treated with long-acting versus short-acting loop diuretics: J-MELODIC subanalysis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T13%3A53%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Changes%20in%20brain%20natriuretic%20peptide%20in%20chronic%20heart%20failure%20patients%20treated%20with%20long-acting%20versus%20short-acting%20loop%20diuretics:%20J-MELODIC%20subanalysis&rft.jtitle=Heart%20and%20vessels&rft.au=Fukui,%20Miho&rft.date=2017-07-01&rft.volume=32&rft.issue=7&rft.spage=865&rft.epage=871&rft.pages=865-871&rft.issn=0910-8327&rft.eissn=1615-2573&rft_id=info:doi/10.1007/s00380-017-0945-z&rft_dat=%3Cproquest_cross%3E1914768638%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1914768638&rft_id=info:pmid/28105515&rfr_iscdi=true |